Skip to Main Content
TABLE 2

CHA IPSO QI Learning Collaborative Aims

Initial Aim Based on Projected Baseline RateMeasured Baseline RateRevised Aim Based on Measured Baseline Rate
Reduce IPSO sepsis 30-d all-cause mortality by 75% from 10.0% to 2.5% by December 2020 30-d sepsis-attributable mortality: IPSO sepsis: 3.1% during 2016; IPSO critical sepsis: 3.6% during 2017 Reduce 30-d sepsis-attributable mortality by at least 25% from the measured baseline rate by December 2020: IPSO sepsis target: 2.3%; IPSO critical sepsis target: 2.7% 
Reduce the incidence of hospital-onset IPSO sepsis by 75% from 2.0% to 0.5% of IPSO suspected infection cases by December 2020 Incidence of hospital-onseta IPSO critical sepsis: 1.3 cases per 1000 hospital admissions during 2017 Reduce the incidence of hospital-onseta IPSO critical sepsis by at least 25% from the measured baseline incidence by December 2020: IPSO critical sepsis target: 1.0 cases per 1000 hospital admissions 
Initial Aim Based on Projected Baseline RateMeasured Baseline RateRevised Aim Based on Measured Baseline Rate
Reduce IPSO sepsis 30-d all-cause mortality by 75% from 10.0% to 2.5% by December 2020 30-d sepsis-attributable mortality: IPSO sepsis: 3.1% during 2016; IPSO critical sepsis: 3.6% during 2017 Reduce 30-d sepsis-attributable mortality by at least 25% from the measured baseline rate by December 2020: IPSO sepsis target: 2.3%; IPSO critical sepsis target: 2.7% 
Reduce the incidence of hospital-onset IPSO sepsis by 75% from 2.0% to 0.5% of IPSO suspected infection cases by December 2020 Incidence of hospital-onseta IPSO critical sepsis: 1.3 cases per 1000 hospital admissions during 2017 Reduce the incidence of hospital-onseta IPSO critical sepsis by at least 25% from the measured baseline incidence by December 2020: IPSO critical sepsis target: 1.0 cases per 1000 hospital admissions 
a

Hospital-onset is defined as occurring ≥12 hours after arrival in the ED or admission to the hospital.

Close Modal

or Create an Account

Close Modal
Close Modal